Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances
June 20, 2024 01:00 ET
|
Avextra AG
Avextra, the leading European vertically-integrated manufacturer and developer of cannabis-based medicines, is expanding its pharmaceutical development capabilities. Behind SynQube GmbH are the two...
Avextra und SynQube GmbH geben eine strategische Partnerschaft in der Arzneimittelentwicklung mit Cannabinoiden und anderen psychotropen Substanzen bekannt
June 20, 2024 01:00 ET
|
Avextra AG
Avextra, der führende europäische vertikal integrierte Hersteller und Entwickler von Medikamenten auf Cannabisbasis, erweitert nach Abschluss seiner Finanzierungsrunde im ersten Quartal 2024 seine...
Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances
June 20, 2024 01:00 ET
|
Avextra AG
Avextra, the leading European vertically-integrated manufacturer and developer of cannabis-based medicines is expanding its pharmaceutical development capabilities. Behind SynQube GmbH are the two...
Avextra AG Announces Closing of Follow-On Capital Raise Supported by Existing and New Institutional Investors
February 07, 2024 07:00 ET
|
Avextra AG
Avextra AG Announces Closing of Follow-On Capital Raise Supported by Existing and New Institutional Investors
German Pain Association (DGS) and Pharmaceutical Company Avextra Join Forces to Launch Their New Study OCEAN
January 23, 2024 03:30 ET
|
Avextra AG
German Pain Association (DGS) and Pharmaceutical Company Avextra Join Forces to Launch Their New Study OCEAN
Avextra Unveils its Alliance for Evidence and Announces its Support of BELCANTO: A Clinical Trial for Oncology Patients
October 18, 2023 07:00 ET
|
Avextra AG
Avextra is launching its Alliance for Evidence-based Cannabis Medicine: a platform focused on collaborating with healthcare professionals and researchers to generate real-world patient data with the...
Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria
September 07, 2023 07:00 ET
|
Avextra AG
Avextra has signed distribution agreements with two pharmaceutical distribution partners in Switzerland and one partner in AustriaAvextra begins exports of standardized cannabis-based medicines from...
Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy
May 17, 2023 07:00 ET
|
Avextra AG
Avextra has successfully exported EU-GMP standardised cannabis extracts manufactured at its German facility to its distribution partner in ItalyAvextra extracts are the first Made in Germany products...
Avextra AG Announces Closing of EU 17 Million Capital Raise
March 15, 2023 08:00 ET
|
Avextra AG
Avextra announces the closing of its EU 17 Million Convertible Loan Note (“CLN”) bridge capital raise. The CLN will automatically swap into equity at the next capital round currently in preparation. ...
Avextra Successfully Exports Oil-Based Cannabis Medicines to the United Kingdom
February 08, 2023 09:00 ET
|
Avextra AG
Avextra successfully exported EU-GMP standardised cannabis extracts manufactured in its German facility to its distribution partner in the United Kingdom Export is a significant milestone that...